advertisement
Xu J 50
Showing records 1 to 25 | Display all abstracts from Xu J105762 Tongqiao Mingmu formula alleviates retinal ganglion cell autophagy through PI3K/AKT/mTOR pathway
Wang L
Anatomical RecordProceedings of the National Academy of Sciences of the United States of America 2023; 306: 3120-3130
106568 The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata
Huang S
European Journal of Dermatology 2022; 32: 589-596
106301 CXC- receptor 2 promotes extracellular matrix production and attenuates migration in peripapillary human scleral fibroblasts under mechanical strain
Qiu C
Journal of cellular and molecular medicine 2022; 26: 5858-5871
106364 A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Jiang J
Ophthalmic Research 2022; 0:
106448 Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Zhang Y
JMIR public health and surveillance 2022; 8: e38182
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Zhao Y
Drug Delivery 2022; 29: 613-623
105762 Tongqiao Mingmu formula alleviates retinal ganglion cell autophagy through PI3K/AKT/mTOR pathway
Yu T
Anatomical RecordProceedings of the National Academy of Sciences of the United States of America 2023; 306: 3120-3130
106448 Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Chen C
JMIR public health and surveillance 2022; 8: e38182
106301 CXC- receptor 2 promotes extracellular matrix production and attenuates migration in peripapillary human scleral fibroblasts under mechanical strain
Wang C
Journal of cellular and molecular medicine 2022; 26: 5858-5871
106364 A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Xu J
Ophthalmic Research 2022; 0:
106568 The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata
Yang Y
European Journal of Dermatology 2022; 32: 589-596
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Huang C
Drug Delivery 2022; 29: 613-623
106448 Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Huang L
JMIR public health and surveillance 2022; 8: e38182
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Zhang Z
Drug Delivery 2022; 29: 613-623
106568 The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata
Ouyang Z
European Journal of Dermatology 2022; 32: 589-596
105762 Tongqiao Mingmu formula alleviates retinal ganglion cell autophagy through PI3K/AKT/mTOR pathway
Dong F
Anatomical RecordProceedings of the National Academy of Sciences of the United States of America 2023; 306: 3120-3130
106364 A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Tao Y
Ophthalmic Research 2022; 0:
106301 CXC- receptor 2 promotes extracellular matrix production and attenuates migration in peripapillary human scleral fibroblasts under mechanical strain
Sun X
Journal of cellular and molecular medicine 2022; 26: 5858-5871
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Hong J
Drug Delivery 2022; 29: 613-623
106364 A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Hu C
Ophthalmic Research 2022; 0:
106301 CXC- receptor 2 promotes extracellular matrix production and attenuates migration in peripapillary human scleral fibroblasts under mechanical strain
Xu J
Journal of cellular and molecular medicine 2022; 26: 5858-5871
105762 Tongqiao Mingmu formula alleviates retinal ganglion cell autophagy through PI3K/AKT/mTOR pathway
Xu J
Anatomical RecordProceedings of the National Academy of Sciences of the United States of America 2023; 306: 3120-3130
106568 The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata
Guo X
European Journal of Dermatology 2022; 32: 589-596
106448 Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Liu G
JMIR public health and surveillance 2022; 8: e38182
106364 A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Zhang C
Ophthalmic Research 2022; 0: